EUVIMEDEUVIMED entdecken
Crossref

Mortality associated with cardiovascular disease in patients with COVID-19

Alberto Cordero, Carlos Santos García-Gallego, Vicente Bertomeu-González, Lorenzo Fácila, Moisés Rodríguez-Mañero, David Escribano, José M. Castellano, Pilar Zuazola, Julio Núñez, Juan J. Badimón, José Ramón González-Juanatey

REC: CardioClinics · 2021-01 · 56 (1) · 30-38

DOI: 10.1016/j.rccl.2020.10.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift REC: CardioClinics, 2021-01. Verfasst von Alberto Cordero und 10 weiteren Autor:innen. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction and objectives Cardiovascular disease (CVD) has been outlined as a possible risk factor for poorer outcomes in patients with COVID-19.

Methods

A meta-analysis was performed with currently available studies that report the prevalence of CVD in survivors vs non-survivors in patients with COVID-19 using reports available at 16 July 2020. Analyses were performed by a random effects model and sensitivity analyses were performed for the identification of potential sources of heterogeneity or to assess the small-study effects.

Results

A total of 307 596 patients from 16 reports were included and 46 321 (15.1%) had CVD. Globally, mortality rate was 8.2% (20 534 patients) and mortality rates were higher in hospital registries (48.7%) compared to national reports (23.1%). A total of 11 213 (24.2%) patients with CVD died and mortality rates were also higher in hospital registries (48.7%) compared to national reports (23.1%). CVD was associated to a 4-fold higher risk of mortality (OR, 4.33; 95%CI, 3.16–5.94). Data from 28 048 patients with diabetes was available. Diabetes was associated to higher mortality risk (OR, 2.41; 95%CI, 1.79–3.26; P < .001). From 40 173 subjects with hypertension it was concluded that hypertension was also a risk factor for higher mortality (OR, 2.60; 95%CI, 2.10–3.21; P < .001).

Conclusions

Patients with CVD and COVID-19 have a 4-fold higher risk of death. Diabetes and hypertension are also associated with higher mortality risk.

Förderung

  • Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares

Zitieren

APA

Cordero, A., García-Gallego, C. S., Bertomeu-González, V., Fácila, L., Rodríguez-Mañero, M., Escribano, D., Castellano, J. M., Zuazola, P., Núñez, J., Badimón, J. J., & González-Juanatey, J. R. (2021). Mortality associated with cardiovascular disease in patients with COVID-19. REC: CardioClinics, 56(1), 30-38. https://doi.org/10.1016/j.rccl.2020.10.005

Vancouver

Cordero A, García-Gallego CS, Bertomeu-González V, Fácila L, Rodríguez-Mañero M, Escribano D, et al. Mortality associated with cardiovascular disease in patients with COVID-19. REC: CardioClinics. 2021;56(1):30-38. doi:10.1016/j.rccl.2020.10.005

BibTeX
@article{Cordero2021,
  author = {Cordero, Alberto and García-Gallego, Carlos Santos and Bertomeu-González, Vicente and Fácila, Lorenzo and Rodríguez-Mañero, Moisés and Escribano, David and Castellano, José M. and Zuazola, Pilar and Núñez, Julio and Badimón, Juan J. and González-Juanatey, José Ramón},
  title = {Mortality associated with cardiovascular disease in patients with COVID-19},
  journal = {REC: CardioClinics},
  year = {2021},
  volume = {56},
  number = {1},
  pages = {30--38},
  doi = {10.1016/j.rccl.2020.10.005}
}
Kostenlos starten →